Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 680

Similar articles for PubMed (Select 17443407)

1.

The association of human immunodeficiency virus infection with spontaneously resolved hepatitis C virus infection and level of viremia among injection drug users.

Seal KH, Monto A, Dove L, Shen H, Vittinghoff E, Tracy D, Miller E, Lau E, Wright TL.

Dig Dis Sci. 2007 Dec;52(12):3423-30. Epub 2007 Apr 19.

PMID:
17443407
2.

The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.

Di Martino V, Rufat P, Boyer N, Renard P, Degos F, Martinot-Peignoux M, Matheron S, Le Moing V, Vachon F, Degott C, Valla D, Marcellin P.

Hepatology. 2001 Dec;34(6):1193-9.

PMID:
11732009
3.

Factors related to the chronicity and evolution of hepatitis C infection in patients co-infected by the human immunodeficiency virus.

Pérez-Cano R, Fernández-Gutiérrez C, López-Suárez A, Mira J, Girón-González JA.

Clin Microbiol Infect. 2002 Sep;8(9):589-97.

4.

Relationship of hepatitis C viremia to HIV state and to infection by specific hepatitis C genotypes.

Pérez-Gracia T, Galán F, Fernández-Gutiérrez C, Girón JA, Rodríguez-Iglesias M.

Liver. 1999 Aug;19(4):288-93.

PMID:
10459626
5.

Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.

Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD; HepaI.Co.N.A. Study Group; Italian Cohort Naive for Antiretrovirals Study Group.

Clin Infect Dis. 2005 Jun 15;40(12):e101-9. Epub 2005 May 5.

7.

Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus.

Saadoun D, Aaron L, Resche-Rigon M, Pialoux G, Piette JC, Cacoub P; GERMIVIC Study Group.

AIDS. 2006 Apr 4;20(6):871-7.

PMID:
16549971
8.

The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users.

Strasfeld L, Lo Y, Netski D, Thomas DL, Klein RS.

J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):356-64.

PMID:
12843747
9.

Hepatitis C virus load and survival among injection drug users in the United States.

Hisada M, Chatterjee N, Kalaylioglu Z, Battjes RJ, Goedert JJ.

Hepatology. 2005 Dec;42(6):1446-52.

PMID:
16317675
10.

Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: influence of antiretroviral therapy.

Yokozaki S, Takamatsu J, Nakano I, Katano Y, Toyoda H, Hayashi K, Hayakawa T, Fukuda Y.

Blood. 2000 Dec 15;96(13):4293-9.

11.

Response-guided therapy for chronic hepatitis C virus infection in patients coinfected with HIV: a pilot trial.

Van den Eynde E, Crespo M, Esteban JI, Jardi R, Ribera E, Carbonell J, Rodríguez-Frias F, Falco V, Curran A, Imaz A, Villar del Saz S, Ocaña I, Esteban R, Pahissa A.

Clin Infect Dis. 2009 Apr 15;48(8):1152-9. doi: 10.1086/597470. Erratum in: Clin Infect Dis. 2009 Aug 1;49(3):489.

12.

Eligibility and feasibility of the treatment of chronic hepatitis C in a Cohort of Italian HIV-positive patients at a single HIV reference center.

Angeli E, Mainini A, Meraviglia P, Schiavini M, Ricci E, Giorgi R, Gubertini G, Rizzardini G.

AIDS Patient Care STDS. 2011 May;25(5):295-301. doi: 10.1089/apc.2010.0342. Epub 2011 Apr 2.

PMID:
21457054
13.
14.

Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus.

Bonacini M, Lin HJ, Hollinger FB.

J Acquir Immune Defic Syndr. 2001 Apr 1;26(4):340-4.

PMID:
11317075
15.

Chronic hepatitis B and other correlates of spontaneous clearance of hepatitis C virus among HIV-infected people with hemophilia.

Melendez-Morales L, Konkle BA, Preiss L, Zhang M, Mathew P, Eyster ME, Goedert JJ.

AIDS. 2007 Jul 31;21(12):1631-6.

PMID:
17630559
16.

[Effects of double and triple antiretroviral agents on the HCV viral load in patients coinfected with HIV and HCV].

Gavazzi G, Richallet G, Morand P, Bouchard O, Bosseray A, Leclercq P, Micoud M.

Pathol Biol (Paris). 1998 Jun;46(6):412-5. French.

PMID:
9769871
17.

Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs.

Ghany MG, Leissinger C, Lagier R, Sanchez-Pescador R, Lok AS.

Dig Dis Sci. 1996 Jun;41(6):1265-72.

PMID:
8654162
18.

GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype.

Schwarze-Zander C, Blackard JT, Zheng H, Addo MM, Lin W, Robbins GK, Sherman KE, Zdunek D, Hess G, Chung RT; AIDS Clinical Trial Group A5071 Study Team.

J Infect Dis. 2006 Aug 15;194(4):410-9. Epub 2006 Jul 12.

19.

Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infection.

Dore GJ, Torriani FJ, Rodriguez-Torres M, Bräu N, Sulkowski M, Lamoglia RS, Tural C, Clumeck N, Nelson MR, Mendes-Correa MC, Godofsky EW, Dieterich DT, Yetzer E, Lissen E, Cooper DA.

AIDS. 2007 Jul 31;21(12):1555-9.

PMID:
17630550
20.

Hepatitis C virus reinfection in injection drug users.

Grebely J, Conway B, Raffa JD, Lai C, Krajden M, Tyndall MW.

Hepatology. 2006 Nov;44(5):1139-45.

PMID:
17058216
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk